Transgenex Nanobiotech Inc.

UEI
CNWNKZL5QXM1
CAGE
3YST2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
transgenex.com
Founded
2004
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Transgenex Nanobiotech Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
: sbir phase II, topic 326: development of novel therapeutic agents that target cancer Contract · HHSN261201700002C National Cancer Institute $1,474,850
"sbir phase i - fiss-CSC: a fiber-inspired smart scaffold platform for expanding cancer stem cells" Contract · HHSN261201500065C National Cancer Institute $225,000
Definitive Contract HHSN261201400022C Contract · HHSN261201400022C National Cancer Institute $224,999
Anti- npra inhibitors targeting cancer stem cells in tumoroids Contract · HHSN261201400028C National Cancer Institute $224,999
Sbir PH i topic 314 fibrous scaffold-induced spheroids mimicking TME Contract · HHSN261201300044C National Cancer Institute $299,992

Quick answers

What is Transgenex Nanobiotech Inc.'s UEI?

Transgenex Nanobiotech Inc.'s Unique Entity ID (UEI) in SAM.gov is CNWNKZL5QXM1.

What is Transgenex Nanobiotech Inc.'s CAGE code?

Transgenex Nanobiotech Inc.'s CAGE code is 3YST2.

What is Transgenex Nanobiotech Inc.'s primary NAICS code?

Transgenex Nanobiotech Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Transgenex Nanobiotech Inc. registered in SAM.gov?

Transgenex Nanobiotech Inc.'s SAM.gov registration expired on November 26, 2025.

What is Transgenex Nanobiotech Inc.'s most recent federal award?

Transgenex Nanobiotech Inc.'s most recent federal contract award is : sbir phase II, topic 326: development of novel therapeutic agents that target cancer (HHSN261201700002C), from National Cancer Institute, on February 1, 2017.

On GovTribe

See Transgenex Nanobiotech Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login